KLRK1 and melanoma: Patients with cervical intraepithelial neoplasia grade 1 13, 14, colon cancer 15 and melanoma who were pre‐treated with a multityrosine kinase inhibitor (sorafenib) also exhibit enhanced frequencies of CD4+ NKG2D+ T cells 16.